What is SB-509 Injections?

Category: Others

false

SB-509 is a Phase 2 Repeat-Dosing Clinical Trial of SB-509 in Subjects With Amyotrophic Lateral Sclerosis.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 0
Mild 0
None 1

Commonly reported side effects and conditions associated with SB-509 Injections

Side effect Patients

Why patients stopped taking SB-509 Injections

Multiple reasons could be selected

Reason Patients
Course of treatment ended 1
See 1 patient who's stopped using SB-509 Injections

Duration

Stopped using SB-509 Injections

Duration Patients
Less than 1 month 1
Adherence
Adherence Evaluations
Always 1
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 1
Not at all hard to take 0
Last updated:

1 patient evaluation for SB-509 Injections

Sep 1, 2009 (Started Sep 01, 2009)

  • Effectiveness
    Moderate (for Experimental)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: 300 mg One time

  • 0 helpful marks
Last updated:
Showing 1 of 1 patient evaluation for SB-509 Injections